Stock & Company Details
Cogent Biosciences Inc $COGT
Price:
N/A
N/A
174M
$5.6B
52 Week High:
N/A
10 Day Average Volume:
N/A
-12.71
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
COGT technical indicators
Latest Cogent Biosciences Inc (COGT) indicator readings as of 2026-10-29.
COGT's 14-day RSI is 53.9, in neutral territory. At $31.96 it is trading 10.6% below its 200-day moving average of $35.74, and below its 50-day average of $32.51. Price sits near the upper Bollinger Band ($28.30 to $32.78). ADX reads 21.6, sitting between trending and range-bound.
Overview
Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, PLX9486, is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. KIT D816V is responsible for driving systemic mastocytosis, a serious disease caused by unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Cogent Biosciences is headquartered in Cambridge, MA.
Finance Bot
Ask your questions
Start by typing a question below.
